search
Back to results

Ultrasound-guided Erector Spinae Plane Blocks

Primary Purpose

Rib Fractures

Status
Completed
Phase
Early Phase 1
Locations
United States
Study Type
Interventional
Intervention
EPSB for rib fractures
Ropivacaine
Sponsored by
Mayo Clinic
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Rib Fractures

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Patients 18 years old or older.
  • Patients with one or more acute traumatic rib fractures.

Exclusion Criteria:

  • Inability to position appropriately.
  • Unconscious or heavily sedated.
  • Patients who are critically ill such that care should not be delayed for regional anesthesia.
  • Patients under the age of 18 years old.
  • Vulnerable populations including prison inmates and pregnant patients.
  • Overlying skin infection, wound, or dressing/equipment (i.e., Chest tube).
  • Inability to visualize target anatomy or by ultrasound or anatomy prohibitive for other reasons to perform procedure successfully.
  • Known or documented allergy to ropivacaine or other amide local anesthetic.

Sites / Locations

  • Mayo Clinic in Rochester

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

EPSB for rib fractures

Arm Description

EPSB for rib fractures

Outcomes

Primary Outcome Measures

Procedural success rate
Measuring the Number of successful ESPB procedures performed in the ED and ICU

Secondary Outcome Measures

Full Information

First Posted
May 20, 2021
Last Updated
June 27, 2023
Sponsor
Mayo Clinic
search

1. Study Identification

Unique Protocol Identification Number
NCT04916691
Brief Title
Ultrasound-guided Erector Spinae Plane Blocks
Official Title
Erector Spinae Plane Block for Rib Fractures: A Pilot Study
Study Type
Interventional

2. Study Status

Record Verification Date
June 2023
Overall Recruitment Status
Completed
Study Start Date
May 15, 2021 (Actual)
Primary Completion Date
August 22, 2022 (Actual)
Study Completion Date
August 22, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Mayo Clinic

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to determine the feasibility of using the ultrasound-guided erector spinae plane blocks to provide additional pain relief to patients with rib fractures in the Emergency Department (ED) and Intensive Care Unit (ICU).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Rib Fractures

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Early Phase 1
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
40 (Actual)

8. Arms, Groups, and Interventions

Arm Title
EPSB for rib fractures
Arm Type
Other
Arm Description
EPSB for rib fractures
Intervention Type
Procedure
Intervention Name(s)
EPSB for rib fractures
Intervention Description
EPSB for rib fractures
Intervention Type
Drug
Intervention Name(s)
Ropivacaine
Intervention Description
Standard of care weight-based optimal Ropivacaine dosing for ESPB
Primary Outcome Measure Information:
Title
Procedural success rate
Description
Measuring the Number of successful ESPB procedures performed in the ED and ICU
Time Frame
12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Patients 18 years old or older. Patients with one or more acute traumatic rib fractures. Exclusion Criteria: Inability to position appropriately. Unconscious or heavily sedated. Patients who are critically ill such that care should not be delayed for regional anesthesia. Patients under the age of 18 years old. Vulnerable populations including prison inmates and pregnant patients. Overlying skin infection, wound, or dressing/equipment (i.e., Chest tube). Inability to visualize target anatomy or by ultrasound or anatomy prohibitive for other reasons to perform procedure successfully. Known or documented allergy to ropivacaine or other amide local anesthetic.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Daniel Stephens, MD
Organizational Affiliation
Mayo Clinic
Official's Role
Principal Investigator
Facility Information:
Facility Name
Mayo Clinic in Rochester
City
Rochester
State/Province
Minnesota
ZIP/Postal Code
55905
Country
United States

12. IPD Sharing Statement

Links:
URL
https://www.mayo.edu/research/clinical-trials
Description
Mayo Clinic Clinical Trials

Learn more about this trial

Ultrasound-guided Erector Spinae Plane Blocks

We'll reach out to this number within 24 hrs